No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas

Mutations in the gene encoding isocitrate dehydrogenase 1 (IDH1) have been identified in approximately 70-80 % of astrocytomas and oligodendrogliomas of WHO grades II and III, and in secondary glioblastomas. In addition, a low incidence of IDH2 mutations has been detected in these tumors, and the oc...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahmadi, Rezvan (Author) , Becker, Natalia (Author) , Dictus, Christine (Author) , Herold-Mende, Christel (Author) , Unterberg, Andreas (Author) , Capper, David (Author) , Deimling, Andreas von (Author) , Wick, Wolfgang (Author)
Format: Article (Journal)
Language:English
Published: 19 April 2012
In: Journal of neuro-oncology
Year: 2012, Volume: 109, Issue: 1, Pages: 15-22
ISSN:1573-7373
DOI:10.1007/s11060-012-0863-y
Online Access:Verlag, Volltext: http://dx.doi.org/10.1007/s11060-012-0863-y
Verlag, Volltext: https://link.springer.com/article/10.1007/s11060-012-0863-y
Get full text
Author Notes:Rezvan Ahmadi, Florian Stockhammer, Natalia Becker, Katarina Hohlen, Martin Misch, Arne Christians, Christine Dictus, Christel Herold-Mende, David Capper, Andreas Unterberg, Andreas von Deimling, Wolfgang Wick, Christian Hartmann

MARC

LEADER 00000caa a2200000 c 4500
001 1572017813
003 DE-627
005 20220814113444.0
007 cr uuu---uuuuu
008 180416s2012 xx |||||o 00| ||eng c
024 7 |a 10.1007/s11060-012-0863-y  |2 doi 
035 |a (DE-627)1572017813 
035 |a (DE-576)502017813 
035 |a (DE-599)BSZ502017813 
035 |a (OCoLC)1341007119 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Ahmadi, Rezvan  |d 1967-  |e VerfasserIn  |0 (DE-588)123535921  |0 (DE-627)706337158  |0 (DE-576)293755027  |4 aut 
245 1 0 |a No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas  |c Rezvan Ahmadi, Florian Stockhammer, Natalia Becker, Katarina Hohlen, Martin Misch, Arne Christians, Christine Dictus, Christel Herold-Mende, David Capper, Andreas Unterberg, Andreas von Deimling, Wolfgang Wick, Christian Hartmann 
264 1 |c 19 April 2012 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.01.2019 
520 |a Mutations in the gene encoding isocitrate dehydrogenase 1 (IDH1) have been identified in approximately 70-80 % of astrocytomas and oligodendrogliomas of WHO grades II and III, and in secondary glioblastomas. In addition, a low incidence of IDH2 mutations has been detected in these tumors, and the occurence of IDH1 and IDH2 mutations is mutually exclusive. For patients with anaplastic gliomas and glioblastomas with IDH1 mutations, overall survival was significantly longer than for patients with wild-type tumours. However, the prognostic value of IDH1 in low-grade gliomas remains ambiguous. IDH1 codon 132 and IDH2 codon 172 mutation status were determined by direct sequencing for a retrospective series of 100 patients with histologically diagnosed Astrocytomas WHO Grad II (A II), and investigated for association with patient outcome. For the patient cohort analysed, median progression-free survival (PFS) was 44.6 months (95 %-CI 1.0-267.0), time to progression (median time to malignant progression (TtMP) was 74.9 months (95 %-CI 1.6-236.2), and median overall survival (OS) was 81.4 months (95 %-CI 5.5-274.8). IDH1 mutations were identified in 79 % of the patients. IDH2 mutations were not observed. Univariate and multivariate analysis revealed no association between IDH1 mutation status and PFS, TtMP, and OS. Furthermore, there were no significant differences regarding PFS, TtMP, and OS between patients with and without IDH1 mutations who did not receive adjuvant treatment. The prognostic value of IDH1 mutations in low-grade astrocytomas is rather low compared with that in high-grade gliomas. 
700 1 |a Becker, Natalia  |d 1976-  |e VerfasserIn  |0 (DE-588)1019237287  |0 (DE-627)684599635  |0 (DE-576)357290283  |4 aut 
700 1 |a Dictus, Christine  |d 1977-  |e VerfasserIn  |0 (DE-588)133291723  |0 (DE-627)691318484  |0 (DE-576)276113543  |4 aut 
700 1 |a Herold-Mende, Christel  |e VerfasserIn  |0 (DE-588)1022936549  |0 (DE-627)717335577  |0 (DE-576)366194267  |4 aut 
700 1 |a Unterberg, Andreas  |e VerfasserIn  |0 (DE-588)1032681187  |0 (DE-627)738641200  |0 (DE-576)168441233  |4 aut 
700 1 |a Capper, David  |d 1979-  |e VerfasserIn  |0 (DE-588)133950751  |0 (DE-627)558829902  |0 (DE-576)300212402  |4 aut 
700 1 |a Deimling, Andreas von  |d 1959-  |e VerfasserIn  |0 (DE-588)103034115X  |0 (DE-627)735093946  |0 (DE-576)378138065  |4 aut 
700 1 |a Wick, Wolfgang  |d 1970-  |e VerfasserIn  |0 (DE-588)120297736  |0 (DE-627)080586929  |0 (DE-576)186221320  |4 aut 
773 0 8 |i Enthalten in  |t Journal of neuro-oncology  |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 1983  |g 109(2012), 1, Seite 15-22  |h Online-Ressource  |w (DE-627)32046122X  |w (DE-600)2007293-4  |w (DE-576)107058944  |x 1573-7373  |7 nnas  |a No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas 
773 1 8 |g volume:109  |g year:2012  |g number:1  |g pages:15-22  |g extent:8  |a No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas 
856 4 0 |u http://dx.doi.org/10.1007/s11060-012-0863-y  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://link.springer.com/article/10.1007/s11060-012-0863-y  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180416 
993 |a Article 
994 |a 2012 
998 |g 120297736  |a Wick, Wolfgang  |m 120297736:Wick, Wolfgang  |d 910000  |d 911100  |e 910000PW120297736  |e 911100PW120297736  |k 0/910000/  |k 1/910000/911100/  |p 12 
998 |g 103034115X  |a Deimling, Andreas von  |m 103034115X:Deimling, Andreas von  |d 910000  |d 912000  |e 910000PD103034115X  |e 912000PD103034115X  |k 0/910000/  |k 1/910000/912000/  |p 11 
998 |g 133950751  |a Capper, David  |m 133950751:Capper, David  |d 910000  |d 912000  |e 910000PC133950751  |e 912000PC133950751  |k 0/910000/  |k 1/910000/912000/  |p 9 
998 |g 1032681187  |a Unterberg, Andreas  |m 1032681187:Unterberg, Andreas  |d 910000  |d 911200  |e 910000PU1032681187  |e 911200PU1032681187  |k 0/910000/  |k 1/910000/911200/  |p 10 
998 |g 1022936549  |a Herold-Mende, Christel  |m 1022936549:Herold-Mende, Christel  |d 910000  |d 911200  |e 910000PH1022936549  |e 911200PH1022936549  |k 0/910000/  |k 1/910000/911200/  |p 8 
998 |g 133291723  |a Dictus, Christine  |m 133291723:Dictus, Christine  |d 910000  |d 911200  |e 910000PD133291723  |e 911200PD133291723  |k 0/910000/  |k 1/910000/911200/  |p 7 
998 |g 1019237287  |a Becker, Natalia  |m 1019237287:Becker, Natalia  |p 3 
998 |g 123535921  |a Ahmadi, Rezvan  |m 123535921:Ahmadi, Rezvan  |d 910000  |d 911200  |e 910000PA123535921  |e 911200PA123535921  |k 0/910000/  |k 1/910000/911200/  |p 1  |x j 
999 |a KXP-PPN1572017813  |e 3006140508 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Rezvan Ahmadi, Florian Stockhammer, Natalia Becker, Katarina Hohlen, Martin Misch, Arne Christians, Christine Dictus, Christel Herold-Mende, David Capper, Andreas Unterberg, Andreas von Deimling, Wolfgang Wick, Christian Hartmann"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas","title":"No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomas"}],"physDesc":[{"extent":"8 S."}],"note":["Gesehen am 09.01.2019"],"id":{"doi":["10.1007/s11060-012-0863-y"],"eki":["1572017813"]},"recId":"1572017813","person":[{"family":"Ahmadi","role":"aut","given":"Rezvan","display":"Ahmadi, Rezvan"},{"display":"Becker, Natalia","given":"Natalia","family":"Becker","role":"aut"},{"display":"Dictus, Christine","family":"Dictus","role":"aut","given":"Christine"},{"role":"aut","family":"Herold-Mende","given":"Christel","display":"Herold-Mende, Christel"},{"display":"Unterberg, Andreas","given":"Andreas","family":"Unterberg","role":"aut"},{"display":"Capper, David","given":"David","role":"aut","family":"Capper"},{"given":"Andreas von","family":"Deimling","role":"aut","display":"Deimling, Andreas von"},{"given":"Wolfgang","family":"Wick","role":"aut","display":"Wick, Wolfgang"}],"language":["eng"],"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"19 April 2012"}],"relHost":[{"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"No prognostic value of IDH1 mutations in a series of 100 WHO grade II astrocytomasJournal of neuro-oncology","physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Journal of neuro-oncology","title":"Journal of neuro-oncology"}],"note":["Gesehen am 11.06.2018","Fortsetzung der Druck-Ausgabe"],"recId":"32046122X","id":{"issn":["1573-7373"],"zdb":["2007293-4"],"eki":["32046122X"]},"origin":[{"publisher":"Springer Science + Business Media B.V ; Kluwer","dateIssuedDisp":"1983-","publisherPlace":"Dordrecht [u.a.] ; Dordrecht [u.a.]","dateIssuedKey":"1983"}],"language":["eng"],"pubHistory":["1.1983 -"],"part":{"issue":"1","pages":"15-22","year":"2012","extent":"8","volume":"109","text":"109(2012), 1, Seite 15-22"}}]} 
SRT |a AHMADIREZVNOPROGNOST1920